lactic acid has been researched along with loteprednol etabonate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bocca, N; Bodor, N; Buchwald, P; Hochhaus, G; Inverardi, L; Kenyon, NS; Marzorati, S; Molano, RD; Pileggi, A; Ricordi, C; Stabler, C | 1 |
| Bodor, N; Buchwald, P; Hochhaus, G; Pinto, E; Song, S; Zhang, B | 1 |
| Sah, AK; Suresh, PK; Verma, VK | 1 |
| Sah, AK; Suresh, PK | 1 |
4 other study(ies) available for lactic acid and loteprednol etabonate
| Article | Year |
|---|---|
Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantation.
Topics: Algorithms; Androstadienes; Animals; Biotechnology; Cell Transplantation; Computer Simulation; Delayed-Action Preparations; Drug Delivery Systems; Drug Implants; Feasibility Studies; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Islets of Langerhans Transplantation; Kaplan-Meier Estimate; Lactic Acid; Loteprednol Etabonate; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pregnancy; Rats; Tissue Distribution | 2010 |
Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant.
Topics: Algorithms; Androstadienes; Animals; Cell Line; Cell Survival; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Excipients; Feasibility Studies; Humans; Immunosuppressive Agents; Indicators and Reagents; Islets of Langerhans Transplantation; Lactic Acid; Loteprednol Etabonate; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Solubility; Solvents; X-Ray Diffraction | 2010 |
PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study.
Topics: Administration, Ophthalmic; Animals; Cornea; Drug Delivery Systems; Eye Diseases; Goats; Lactic Acid; Loteprednol Etabonate; Nanoparticles; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization.
Topics: Administration, Ophthalmic; Drug Carriers; Drug Liberation; Lactic Acid; Loteprednol Etabonate; Nanoparticles; Particle Size; Polyglycolic Acid; Polymers | 2017 |